DOXORUBICIN ACCORD doxorubicin hydrochloride 200 mg/100 mL concentrated solution for injection vial - medicine shortage information

Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details	Supply Impact Dates	Further Details
DOXORUBICIN ACCORD doxorubicin hydrochloride 200 mg/100 mL concentrated solution for injection vial AUST R: 174248 Active ingredients: doxorubicin hydrochloride Dosage form: Injection, concentrated Sponsor: Accord Healthcare Pty Ltd Phone: 1800 222 673	From 18 Nov 2024 to 17 Jan 2025	Shortage status: Current Availability: Limited Availability Reason: Manufacturing Management action: Alternative generic products are available. An unregistered product has been approved for supply under Section 19A. The approval holder, Accord Healthcare Pty Ltd, can be contacted for details on supply on 1800 222 673.

Product details

Supply Impact Dates

Further Details

DOXORUBICIN ACCORD doxorubicin hydrochloride 200 mg/100 mL concentrated solution for injection vial
AUST R: 174248
Active ingredients:
doxorubicin hydrochloride

Dosage form:
Injection, concentrated

Sponsor:
Accord Healthcare Pty Ltd

Phone:
1800 222 673

From
18 Nov 2024
to
17 Jan 2025

Shortage status:
Current

Availability:
Limited Availability

Reason:
Manufacturing

Management action:
Alternative generic products are available. An unregistered product has been approved for supply under Section 19A. The approval holder, Accord Healthcare Pty Ltd, can be contacted for details on supply on 1800 222 673.